Assignee
EOLAS THERAPEUTICS INC
US·4 granted patents·24 citations·filing 2014–2016
Top patents by PatentIndex Score
4 records- 0185US10221170B2Difluoropyrrolidines as orexin receptor modulatorsEOLAS THERAPEUTICS INC·Filed 2015·Granted Mar 5, 2019·7 cites·28 claims
- 0285US9440982B2Substituted prolines/piperidines as orexin receptor antagonistsEOLAS THERAPEUTICS INC·Filed 2014·Granted Sep 13, 2016·5 cites·26 claims
- 0383US9896452B2Substituted prolines/piperidines as orexin receptor antagonistsEOLAS THERAPEUTICS INC·Filed 2016·Granted Feb 20, 2018·5 cites·23 claims
- 0483US9499517B2Substituted prolines / piperidines as orexin receptor antagonistsEOLAS THERAPEUTICS INC·Filed 2014·Granted Nov 22, 2016·7 cites·12 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →